fbpx
Skip to content
Force Pharma Capital

Force Pharma Capital

Life Science Consulting, Business Development and Recruiting/Staffing
  • Home
  • About Us
  • Services
  • Pharmaceutical Blog
    • RLD
    • Excipients
    • Equipment
    • Health Technology
    • Regulatory Fees
  • Contact Us
  • FAQ
  • Portfolio

Pharmaceutical Information Blog

Channel in Nerve Cell May be Key in Unlocking Parkinson Disease Therapy

December 3, 2019 Blogger

Researchers have identified a channel in nerve cells that may serve as a new approach to targeting Parkinson disease. —…

Continue Reading →

Posted in: Health Technology Filed under: fixed dose combination, technology

Drug Trials Snapshots BRUKINSA | FDA

December 1, 2019 Blogger

Drug Trials Snapshots — Read on www.fda.gov/drugs/resources-information-approved-drugs/drug-trials-snapshots-brukinsa More inhibitors for oncology.

Continue Reading →

Posted in: Health Technology Filed under: approvals, FDA, pdufa

FDA Report: Changes in Marketplace Needed to Mitigate Drug Shortages

November 3, 2019 Blogger

The FDA Drug Shortages Task Force addressed the root causes of drug shortages and proposed potential solutions. — Read on…

Continue Reading →

Posted in: Health Technology Filed under: FDA

FDA Announces Availability of Draft Guidance – Type V DMFs for CDER-Led Combination Products Using Device Constituent Parts with Electronics or Software

October 28, 2019 Blogger

FDA Announces Availability of Draft Guidance – Type V DMFs for CDER-Led Combination Products Using Device Constituent Parts with Electronics…

Continue Reading →

Posted in: Health Technology Filed under: FDA, fixed dose combination

FDA approves new breakthrough therapy for cystic fibrosis | FDA

October 21, 2019 Blogger

FDA approves breakthrough therapy Trikafta for patients 12 and older with cystic fibrosis who have at least one F508del mutation…

Continue Reading →

Posted in: Health Technology Filed under: approvals, FDA, fixed dose combination, pdufa, technology

Blocking Inflammatory Pathway May Stop Brain Metastasis from Melanoma

October 20, 2019 Blogger

Melanoma brain metastasis occurs when tumor cells hijack an inflammatory pathway in the brain and blocking this pathway could prevent…

Continue Reading →

Posted in: Health Technology Filed under: FDA, technology

FDA Announces Availability of Draft Guidance – Drug Master Files

October 18, 2019 Blogger

FDA Announces Availability of Draft Guidance – Drug Master Files — Read on s2027422842.t.en25.com/e/es

Continue Reading →

Posted in: Uncategorized Filed under: FDA

Ceritinib Response Seen in Study of Brain Metastases in ALK-Positive NSCLC

October 12, 2019 Blogger

“The efficacy of ceritinib was evaluated in patients who have ALK-positive non-small cell lung cancer with active brain metastases.” —…

Continue Reading →

Posted in: Health Technology Filed under: FDA, pdufa

FDA approves new treatment for patients with migraine | FDA

October 11, 2019 Blogger

The U.S. Food and Drug Administration today approved Reyvow (lasmiditan) tablets for the acute (active but short-term) treatment of migraine…

Continue Reading →

Posted in: Uncategorized Filed under: approvals, pdufa

Treating Pancreatic Cancer by Altering the Tumor Microbiome – National Cancer Institute

October 1, 2019 Blogger

In people with pancreatic cancer, the composition of their tumor microbiome might predict how long they live, according to a…

Continue Reading →

Posted in: Health Technology Filed under: fixed dose combination

Post navigation

Page 2 of 7
← Previous 1 2 3 … 7 Next →

Follow Us

Contact Us

  • Email
    forcepharma@icloud.com
  • Phone
    732-702-1824
  • Address
    265 Route 34 Lower Level, Colts Neck, New Jersey, 07722
Copyright © 2018 Force Pharma Capital